Overview
The DIA India Annual Meeting is a premier platform that brings together diverse stakeholders from the life sciences, pharmaceutical, and healthcare industries. The conference serves as a hub for innovation, collaboration, and knowledge sharing, addressing key challenges and opportunities across the drug development spectrum. With a focus on advancing healthcare solutions, the meeting fosters discussions that drive impactful outcomes for patients, industry professionals, and regulators alike.
This year’s meeting, DIA India 2025, will feature multiple tracks, covering critical areas such as Clinical Trial Innovation, Pharmacovigilance, Regulatory Science, CMC & Product Quality, Medical Affairs, and Data Science, RWE, and Artificial Intelligence. Each track offers a unique opportunity to explore emerging trends, cutting-edge technologies, and best practices shaping the future of life sciences. Attendees will engage with thought leaders, exchange ideas, and collaborate on solutions to address the evolving needs of the global healthcare ecosystem.
Program Committee
-
Fahd Khan Head Business Development - APAC
Emmes, India -
Manjusha Rajarshi Founder Regulus Healthcare
Partner at roots-simplified Research and Consulting LLP, India -
Sonica Sachdeva Batra, MD Associate Vice President Enterprise Medical Head- Regulatory Solutions
Indegene, India -
Sanish Davis Director R&D
Janssen Pharmaceutical, India -
Moin Don Founder and CEO, PVCON Consulting, Lead: South Asia Chapter (ISoP),
International Society of Pharmacovigilance (ISoP), India -
Gaurav Mathur, PhD Manager, Regulatory Affairs
INC GVK Bio, India -
Viraj Suvarna Independent Healthcare Consultant
Know Medical Know Business , India
Have an account?